Mohs surgery

Kerecis to Present Scientific and Clinical Updates on Fish-Skin Grafts at the Symposium on Advanced Wound Care Spring

Retrieved on: 
Dienstag, Mai 14, 2024
Surgery, Medical Devices, Hospitals, Health Technology, Stem Cells, Biotechnology, Other Health, Health, General Health, Patient, Mohs surgery, FNP, SAWC, Achilles tendon, Skin, DPM, Dicarboxylic acid, Research, WOCN, Regenerative medicine, Abstract, Multimedia, Foot, Female

Kerecis , the pioneer in the use of fish skin and fatty acids for tissue regeneration and protection, will unveil its latest scientific and clinical updates, including trial results, at the upcoming Symposium on Advanced Wound Care (SAWC) Spring.

Key Points: 
  • Kerecis , the pioneer in the use of fish skin and fatty acids for tissue regeneration and protection, will unveil its latest scientific and clinical updates, including trial results, at the upcoming Symposium on Advanced Wound Care (SAWC) Spring.
  • Kerecis will exhibit at booth 419 at SAWC, which will take place from May 14 to 18 in Orlando, Florida.
  • “Our ongoing research and data underscore significantly improved healing times, reduced complications, and enhanced patient outcomes across different clinical settings.
  • During a hands-on skills lab, Kerecis medical affairs program managers will demonstrate Kerecis products, highlighting advanced applications in real-world clinical settings.

SkinCure Oncology’s GentleCure™ Experience to be Featured in National Public Health PSA Series

Retrieved on: 
Mittwoch, Mai 8, 2024
FDA, Bangladesh Technical Education Board, Mohs surgery, Skin, PSA, Health, Skin cancer, Medical statistics, Government, Society, Vision, Dermatology

The PSA is being produced independently by World Impact Productions as part of the acclaimed “Breakthrough” TV PSA series.

Key Points: 
  • The PSA is being produced independently by World Impact Productions as part of the acclaimed “Breakthrough” TV PSA series.
  • The educational public health series has been developed in collaboration with input from the National Center for Health Statistics, the National Institutes of Health and various think tanks and government agencies.
  • The order, placed in fourth quarter 2023, provides for delivery of approximately 75 units from fourth quarter 2023 through third quarter 2024.
  • The Company anticipates this will address its needs through ultimate finalization and clearance of its technology currently under development.

Waccamaw Dermatology Opens New Office In Mount Pleasant

Retrieved on: 
Montag, Mai 6, 2024
Mohs, Skin, Carcinoma, Health, Dermatology, Skin cancer, Patient, Physician, Elective surgery, Ageing, Cancer, Mohs surgery, Hospital

MOUNT PLEASANT, S.C., May 6, 2024 /PRNewswire-PRWeb/ -- Waccamaw Dermatology, one of the largest physician-owned and led dermatology practices in the Carolinas, today announced the opening of a new office to serve the Mount Pleasant area. The new office — the eleventh in the multi-award-winning Waccamaw Dermatology practice — expands access to skin cancer screening to a population that needs quality dermatological care. Skin cancer screening is recommended beginning in a person's mid-20s, but studies show it still lags behind screening for other types of cancers. Waccamaw Dermatology currently operates

Key Points: 
  • MOUNT PLEASANT, S.C., May 6, 2024 /PRNewswire-PRWeb/ -- Waccamaw Dermatology , one of the largest physician-owned and led dermatology practices in the Carolinas, today announced the opening of a new office to serve the Mount Pleasant area.
  • The new office — the eleventh in the multi-award-winning Waccamaw Dermatology practice — expands access to skin cancer screening to a population that needs quality dermatological care.
  • Waccamaw Dermatology currently operates
    "Waccamaw Dermatology is committed to providing the best clinical care and patient experience for dermatology patients in the Carolinas," said Brandon J. Coakley, M.D., Board-Certified Dermatologist, fellowship-trained Mohs Surgeon, and Managing Partner of Waccamaw Dermatology.
  • The opening of the new Mount Pleasant office is driven by consistent demand for quality dermatology offices.

DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck

Retrieved on: 
Freitag, Mai 3, 2024
Surgery, Genetics, Clinical Trials, Biotechnology, Biometrics, Health, Pharmaceutical, General Health, Oncology, Radiation, Mohs, NCCN, Mohs surgery, American College, CME, ACMS, Abstract (summary), Neck, National Comprehensive Cancer Network, SCC, Patient, Metastasis, Neoplasm, Head, BWH

“In most cases, once a tumor is removed completely, the patient is in the clear.

Key Points: 
  • “In most cases, once a tumor is removed completely, the patient is in the clear.
  • This study included 417 patients who received definitive Mohs surgery to remove high-risk SCC tumors of the H&N with reported clear margins.
  • Presenting authors will be available to answer questions regarding their posters on Saturday, May 4, from 12-1 p.m. Mountain Standard Time.
  • Abstracts will also be in ACMS' CME & Abstract Book and available for online viewing via the Planstone abstract site.

Survey Shows Stark Difference in Satisfaction Rates Among Skin Cancer Patients Treated Surgically and Nonsurgically

Retrieved on: 
Mittwoch, Mai 1, 2024
Pain, Mohs surgery, Skin, Risk, Private practice, Commonwealth, Dermatology, Skin cancer, SRT, Patient, Medical imaging

The survey involved 3,915 individuals who had been treated for nonmelanoma skin cancer one or more times.

Key Points: 
  • The survey involved 3,915 individuals who had been treated for nonmelanoma skin cancer one or more times.
  • SkinCure Oncology Chief Executive Officer Kerwin Brandt explained, "With GentleCure, we're providing cancer center level of care in the private practice.
  • Dermatologists across the country are celebrating the introduction of this nonsurgical treatment for the nation's most common cancer type – nonmelanoma skin cancer.
  • While May is Skin Cancer Awareness Month, early-adopter skin specialists in 40 states are already providing the GentleCure Experience to patients who prefer to avoid surgery or for whom surgery is not recommended.

Dermatology Association of Radiation Therapy (DART) Opposes Move to Cancel Medicare Coverage for Nonsurgical Treatment of Nonmelanoma Skin Cancer in Seven States

Retrieved on: 
Montag, April 29, 2024
Education, Keloid, LCD, American Academy, Radiation, NCCN, Mohs surgery, Carcinoma, Policy, Skin, DART, National Comprehensive Cancer Network, American Academy of Dermatology, Recurrence, Research, SCC, Comment, Doctor of Philosophy, SRT, Radiation therapy, Documentation, NMSC, Patient, Treatment, Society, AAD, RT, BCC, ASTRO, Health insurance

The proposed LCD at issue, DL39808 " Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) ," would affect residents in North and South Carolina, Virginia, West Virginia, Alabama, Georgia and Tennessee.

Key Points: 
  • The proposed LCD at issue, DL39808 " Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) ," would affect residents in North and South Carolina, Virginia, West Virginia, Alabama, Georgia and Tennessee.
  • The DART filing noted, "In its current form, the LCD is fundamentally misdirected, misguided, and inappropriate.
  • It would altogether remove any semblance of patient choice or physician clinical decision making for patients who are diagnosed with NMSC.
  • At the outset, DART underscores that the proposed LCD was filed as a Medicare Part A policy.

Olansky Dermatology & Aesthetics welcomes physician assistant, expands hours

Retrieved on: 
Dienstag, April 9, 2024
Psoriasis, Skin cancer, Patient, Mohs surgery, Aesthetics, Quality of life, Suite, Dermatology, Acne, Family

ATLANTA, April 09, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– welcomes physician assistant Kathryn “Katie” Shea to its Buckhead location.

Key Points: 
  • ATLANTA, April 09, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– welcomes physician assistant Kathryn “Katie” Shea to its Buckhead location.
  • This addition to the practice’s acclaimed staff allows Olansky Dermatology & Aesthetics the ability to offer new, expanded hours at its Buckhead location, a first for Atlanta area dermatology.
  • She has extensive experience in dermatology and urgent care medicine, and she is a member of the Georgia Association of Physician Assistants, American Academy of Physician Assistants, and Georgia Dermatology Physician Assistants.
  • “We strive to offer our patients the best providers possible,” says Dr. Jodi Ganz, physician partner at Olansky Dermatology & Aesthetics, “By growing our staff, it allows us to better meet patients where they are and provide additional hours for better flexibility.”
    Olansky Dermatology & Aesthetics is your dermatology solution.

Common Skin Cancer, Like Christie Brinkley’s, Can Often Be Cured Without Surgery

Retrieved on: 
Donnerstag, März 14, 2024
Skin, Skin cancer, Patient, SRT, Mohs surgery, Dermatology, Cancer, Insurance, Basal-cell carcinoma, Carcinoma, Patent, Pain, Medicare, Marketing, FDA, Food, Medical imaging

Basal cell carcinoma, which Brinkley had, and squamous cell carcinoma are forms of nonmelanoma skin cancer, the most common type of cancer in the United States.

Key Points: 
  • Basal cell carcinoma, which Brinkley had, and squamous cell carcinoma are forms of nonmelanoma skin cancer, the most common type of cancer in the United States.
  • Brinkley had Mohs surgery, the traditional treatment that dates back to the 1930s,” says dermatologist and surgeon Dr. Janine Hopkins of Hopkins Dermatology, Monroe, Louisiana and Southlake, Texas.
  • The treatment is administered over the course of 15-minute sessions, with no cutting, pain, surgical scarring or need for reconstructive surgery.
  • SkinCure Oncology recently announced receipt of a U.S. patent for a new image-guided technology that will be the fourth generation of SRT.

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

Retrieved on: 
Mittwoch, März 13, 2024
Deal, Keloid, SRT, Dermatology, Mohs surgery, BOCA, Vision, Patent, AAD, FDA, Medical imaging

BOCA RATON, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the successful launch of its new “Fair Deal Agreement” for the SRT-100 Vision™ (IG-SRT) at the AAD 2024 Annual Meeting, held March 8-12 in San Diego. This meeting is the largest gathering of dermatologists in the U.S., hosting more than 10,000 medical personnel at this year’s event.

Key Points: 
  • This meeting is the largest gathering of dermatologists in the U.S., hosting more than 10,000 medical personnel at this year’s event.
  • Sensus manufactures and sells the only proven, FDA-cleared IG-SRT system and holds a patent for SRT combined with ultrasound, which is deeper and more effective.
  • “The AAD Annual Meeting was the ideal forum to launch our new Fair Deal Agreement program, and the response among conference attendees exceeded our most optimistic expectations.
  • This technology is ideal for better managing dermatology clinical practice, and is a Sensus Healthcare exclusive.

Medicare Coverage Is Threatened for the 134,000 North Carolinians Likely to Get Skin Cancer this Year

Retrieved on: 
Dienstag, April 2, 2024
Dermatology, DART, Skin cancer, Federation, Diabetes, Patient, Research, Mohs surgery, Policy, Cancer, Insurance, Judgement, Blue Cross, Blue Shield, Carcinoma, Radiation, Medicare, FDA, Pain, Hearing, Medical imaging

Palmetto GBA, a subsidiary of Blue Cross and Blue Shield of South Carolina, is authorized by the federal government to regulate Medicare in North Carolina and six other states.

Key Points: 
  • Palmetto GBA, a subsidiary of Blue Cross and Blue Shield of South Carolina, is authorized by the federal government to regulate Medicare in North Carolina and six other states.
  • Palmetto is moving quickly to cancel coverage, which has been in effect nearly 10 years.
  • Medicare and private insurers should provide coverage for Image-Guided SRT whenever it's deemed the most suitable therapy by patients and their healthcare providers.
  • Consumers who care about keeping their insurance coverage for the nonsurgical treatment should write to the panel by May 11, at [email protected] .